Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $INCY INCYTE CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 7,511,046 shares
Current Value: $887,655,416
Latest Transaction: Sep 23 2010
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in INCYTE CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.86 | 179,644 | 2,669,654 | 7,511,046 | 7.7 M to 7.5 M (-2.34 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.71 | 227,071 | 3,340,623 | 7,690,690 | 7.9 M to 7.7 M (-2.87 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.94 | 610,072 | 9,116,306 | 7,917,761 | 8.5 M to 7.9 M (-7.15 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.00 | 58,262 | 815,551 | 8,527,833 | 8.6 M to 8.5 M (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.00 | 29,988 | 419,829 | 8,586,095 | 8.6 M to 8.6 M (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.08 | 190,020 | 2,675,729 | 8,616,083 | 8.8 M to 8.6 M (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.09 | 123,602 | 1,741,218 | 8,806,103 | 8.9 M to 8.8 M (-1.38 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 4,367,000 | 48,991,190 | 33,130,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 3,493,000 | 39,186,221 | 42,509,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 788,000 | 8,840,178 | 39,016,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 2,363,000 | 26,509,316 | 38,228,000 | |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.16 | 11,232 | 24,233 | 7,081,505 | 7.1 M to 7.1 M (+0.16 %) |
| Mar 05 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.14 | 9,524 | 20,397 | 7,070,273 | 7.1 M to 7.1 M (+0.13 %) |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 7,878,000 | 88,379,343 | 33,896,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 2,993,000 | 33,576,971 | 26,018,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 7,627,000 | 85,563,500 | 23,025,000 | |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.17 | 15,951 | 34,628 | 7,060,749 | 7 M to 7.1 M (+0.23 %) |
| Mar 02 2009 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.14 | 17,413 | 37,203 | 7,044,798 | 7 M to 7 M (+0.25 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 4,534,000 | 50,871,480 | 34,127,000 | |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 7,598,000 | 85,249,560 | 7,598,000 | |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.60 | 241,712 | 869,051 | 7,027,300 | 6.8 M to 7 M (+3.56 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.62 | 42,834 | 154,952 | 785,588 | 742.8 K to 785.6 K (+5.77 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.56 | 215,917 | 769,377 | 6,742,754 | 6.5 M to 6.7 M (+3.31 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.60 | 13,055 | 46,954 | 6,526,837 | 6.5 M to 6.5 M (+0.20 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.33 | 132,354 | 440,977 | 6,513,782 | 6.4 M to 6.5 M (+2.07 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.33 | 80,201 | 267,406 | 6,381,428 | 6.3 M to 6.4 M (+1.27 %) |
| Dec 19 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 3.15 | 9,259 | 29,166 | 6,301,227 | 6.3 M to 6.3 M (+0.15 %) |
| Aug 05 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.00 | 864,092 | 7,776,828 | 6,291,968 | 5.4 M to 6.3 M (+15.92 %) |
| Jan 31 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 17,781,000 | 199,476,149 | 29,593,000 | |
| Jan 31 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 831,000 | 9,322,574 | 11,812,000 | |
| Jan 31 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Option Exercise | P | 11.22 | 117,000 | 1,312,565 | 10,981,000 | |
| Jan 24 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.62 | 223 | 2,368 | 5,427,876 | 5.4 M to 5.4 M (0.00 %) |
| Jan 16 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.99 | 34,621 | 380,398 | 5,427,653 | 5.4 M to 5.4 M (+0.64 %) |
| Jan 11 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.94 | 30,682 | 335,548 | 5,393,032 | 5.4 M to 5.4 M (+0.57 %) |
| Jan 11 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.01 | 1,241 | 13,657 | 5,362,350 | 5.4 M to 5.4 M (+0.02 %) |
| Jan 11 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.94 | 90,591 | 991,319 | 5,361,109 | 5.3 M to 5.4 M (+1.72 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.00 | 24,154 | 241,434 | 5,270,518 | 5.2 M to 5.3 M (+0.46 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.89 | 458,644 | 4,996,468 | 5,246,364 | 4.8 M to 5.2 M (+9.58 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.48 | 212,282 | 2,012,667 | 4,787,720 | 4.6 M to 4.8 M (+4.64 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.47 | 298,752 | 2,828,166 | 4,575,438 | 4.3 M to 4.6 M (+6.99 %) |
| Dec 19 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.61 | 89,198 | 946,195 | 4,276,686 | 4.2 M to 4.3 M (+2.13 %) |
| Dec 19 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.58 | 53,824 | 569,657 | 4,187,488 | 4.1 M to 4.2 M (+1.30 %) |
| Dec 19 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.60 | 94,565 | 1,001,945 | 4,133,664 | 4 M to 4.1 M (+2.34 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.38 | 170,512 | 1,770,750 | 4,039,099 | 3.9 M to 4 M (+4.41 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.85 | 66,672 | 656,779 | 3,868,587 | 3.8 M to 3.9 M (+1.75 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.87 | 87,770 | 866,465 | 3,801,915 | 3.7 M to 3.8 M (+2.36 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 9.54 | 108,461 | 1,035,184 | 3,714,145 | 3.6 M to 3.7 M (+3.01 %) |
| Dec 06 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.98 | 57,303 | 514,684 | 3,605,684 | 3.5 M to 3.6 M (+1.61 %) |
| Dec 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.96 | 23,842 | 213,665 | 3,548,381 | 3.5 M to 3.5 M (+0.68 %) |
| Dec 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.59 | 54,899 | 471,632 | 3,524,539 | 3.5 M to 3.5 M (+1.58 %) |
| Dec 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.58 | 17,572 | 150,747 | 3,469,640 | 3.5 M to 3.5 M (+0.51 %) |
| Nov 28 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.40 | 127,875 | 1,073,677 | 3,452,068 | 3.3 M to 3.5 M (+3.85 %) |
| Nov 28 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.00 | 198,138 | 1,584,549 | 3,324,193 | 3.1 M to 3.3 M (+6.34 %) |
| Nov 28 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 7.94 | 85,927 | 682,166 | 3,126,055 | 3 M to 3.1 M (+2.83 %) |
| Nov 21 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.12 | 56,010 | 454,801 | 3,040,128 | 3 M to 3 M (+1.88 %) |
| Nov 21 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.10 | 78,415 | 635,271 | 2,984,118 | 2.9 M to 3 M (+2.70 %) |
| Nov 21 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.22 | 144,486 | 1,188,166 | 2,905,703 | 2.8 M to 2.9 M (+5.23 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.30 | 102,285 | 849,221 | 2,761,217 | 2.7 M to 2.8 M (+3.85 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.63 | 151 | 1,303 | 2,658,932 | 2.7 M to 2.7 M (+0.01 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.62 | 108,254 | 933,463 | 2,658,781 | 2.6 M to 2.7 M (+4.24 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.53 | 124,973 | 1,065,732 | 2,550,527 | 2.4 M to 2.6 M (+5.15 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.54 | 1,793 | 15,312 | 2,425,554 | 2.4 M to 2.4 M (+0.07 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.25 | 87,343 | 720,623 | 2,423,761 | 2.3 M to 2.4 M (+3.74 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.26 | 19,844 | 163,882 | 2,336,418 | 2.3 M to 2.3 M (+0.86 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.22 | 14,490 | 119,157 | 2,316,574 | 2.3 M to 2.3 M (+0.63 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.30 | 23,377 | 194,006 | 2,302,084 | 2.3 M to 2.3 M (+1.03 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.00 | 11,165 | 89,268 | 2,278,707 | 2.3 M to 2.3 M (+0.49 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.23 | 21,397 | 176,179 | 2,267,542 | 2.2 M to 2.3 M (+0.95 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.20 | 172,694 | 1,416,177 | 2,246,145 | 2.1 M to 2.2 M (+8.33 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 8.30 | 140,951 | 1,169,907 | 2,073,451 | 1.9 M to 2.1 M (+7.29 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 7.70 | 198,883 | 1,531,936 | 1,932,500 | 1.7 M to 1.9 M (+11.47 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 7.90 | 3,629 | 28,654 | 1,733,617 | 1.7 M to 1.7 M (+0.21 %) |
| Aug 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.83 | 168,797 | 814,564 | 1,729,988 | 1.6 M to 1.7 M (+10.81 %) |
| Aug 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.99 | 46,012 | 229,733 | 1,561,191 | 1.5 M to 1.6 M (+3.04 %) |
| Aug 03 2007 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Buy | P | 4.95 | 237,052 | 1,172,530 | 1,515,179 | 1.3 M to 1.5 M (+18.55 %) |
Page: 1